Advances in Bioinspired Artificial System Enabling Biomarker-Driven Therapy

被引:1
作者
Wang, Meixia [1 ]
Zhong, Huan [1 ]
Li, Yangbing [1 ]
Li, Juan [1 ]
Zhang, Xinxin [1 ]
He, Fang [1 ]
Wei, Ping [2 ]
Wang, Hong-Hui [1 ]
Nie, Zhou [1 ]
机构
[1] Hunan Univ, Coll Biol, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Peoples R China
[2] Chinese Acad Sci, Ctr Cell & Gene Circuit Design, Shenzhen Inst Synthet Biol, Shenzhen Inst Adv Technol,CAS Key Lab Quantitat E, Shenzhen 518055, Peoples R China
基金
中国国家自然科学基金;
关键词
Biomarker; Bioinspired artificial systems; Personalized medicine; Prodrug; CAR-T-CELLS; ALLOSTERY; PRODRUG; LOGIC; ACTIVATION; RECEPTORS; RELEASE; DESIGN;
D O I
10.1002/chem.202401593
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Bioinspired molecular engineering strategies have emerged as powerful tools that significantly enhance the development of novel therapeutics, improving efficacy, specificity, and safety in disease treatment. Recent advancements have focused on identifying and utilizing disease-associated biomarkers to optimize drug activity and address challenges inherent in traditional therapeutics, such as frequent drug administrations, poor patient adherence, and increased risk of adverse effects. In this review, we provide a comprehensive overview of the latest developments in bioinspired artificial systems (BAS) that use molecular engineering to tailor therapeutic responses to drugs in the presence of disease-specific biomarkers. We examine the transition from open-loop systems, which rely on external cues, to closed-loop feedback systems capable of autonomous self-regulation in response to disease-associated biomarkers. We detail various BAS modalities designed to achieve biomarker-driven therapy, including activatable prodrug molecules, smart drug delivery platforms, autonomous artificial cells, and synthetic receptor-based cell therapies, elucidating their operational principles and practical in vivo applications. Finally, we discuss the current challenges and future perspectives in the advancement of BAS-enabled technology and envision that ongoing advancements toward more programmable and customizable BAS-based therapeutics will significantly enhance precision medicine. Biomarker-driven therapy holds significant potential to improve patient outcomes and quality of life. In this review, we explore recent advancements in bioinspired artificial systems and their therapeutic applications, with a particular emphasis on the capabilities of these BAS modalities. We discuss their roles in enabling on-demand activation, targeted drug delivery, intelligent treatment, and precision cell therapy, highlighting how these technologies can lead to more effective and tailored healthcare solutions. image
引用
收藏
页数:17
相关论文
共 107 条
  • [1] Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]
  • [2] Cancer Cell-Selective Membrane Receptor Clustering Driven by VEGF Secretion for In Vivo Therapy
    Bi, Shiyi
    Chen, Wei
    Fang, Yanyun
    Wang, Yingfei
    Zhang, Qing
    Guo, Hongqian
    Ju, Huangxian
    Liu, Ying
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (09) : 5041 - 5052
  • [3] Biomarker definitions and their applications
    Califf, Robert M.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (03) : 213 - 221
  • [4] Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors
    Cattaruzza, Fiore
    Nazeer, Ayesha
    To, Milton
    Hammond, Mikhail
    Koski, Caitlin
    Liu, Lucas Y. Y.
    Yeung, V. Pete
    Rennerfeldt, Deena A. A.
    Henkensiefken, Angela
    Fox, Michael
    Lam, Sharon
    Morrissey, Kari M. M.
    Lange, Zachary
    Podust, Vladimir N. N.
    Derynck, Mika K. K.
    Irving, Bryan A. A.
    Schellenberger, Volker
    [J]. NATURE CANCER, 2023, 4 (04) : 485 - +
  • [5] Cell to Cell Signaling through Light in Artificial Cell Communities: Glowing Predator Lures Prey
    Chakraborty, Taniya
    Wegner, Seraphine, V
    [J]. ACS NANO, 2021, 15 (06) : 9434 - 9444
  • [6] Chang ZNL, 2018, NAT CHEM BIOL, V14, P317, DOI [10.1038/NCHEMBIO.2565, 10.1038/nchembio.2565]
  • [7] The Story of the Little Blue Box: A Tribute to Siegfried Hunig
    Chen, Xiao-Yang
    Chen, Hongliang
    Stoddart, J. Fraser
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2023, 62 (01)
  • [8] Receptor-mediated cell mechanosensing
    Chen, Yunfeng
    Ju, Lining
    Rushdi, Muaz
    Ge, Chenghao
    Zhu, Cheng
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28 (23) : 3134 - 3155
  • [9] Chen ZW, 2018, NAT CHEM BIOL, V14, P86, DOI [10.1038/NCHEMBIO.2511, 10.1038/nchembio.2511]
  • [10] Engineering advanced logic and distributed computing in human CAR immune cells
    Cho, Jang Hwan
    Okuma, Atsushi
    Sofjan, Katri
    Lee, Seunghee
    Collins, James J.
    Wong, Wilson W.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)